Glycerol Fructose Sodium Chloride Injection
Function and Efficacy
[Pharmacology and Toxicology] Glycerol fructose injection is a hypertonic preparation. Through high osmotic dehydration, it can reduce the water content of the brain and reduce intracranial pressure. This product has a slow onset of action in reducing intracranial pressure and lasts for a long time. [Pharmacokinetics] This product enters the body tissues through the blood, and its distribution reaches equilibrium in about 2 to 3 hours. It enters the cerebrospinal fluid and brain tissue slowly and is cleared slowly. Most of this product is metabolized to CO2 and water for excretion.
Ingredients
Glycerin, fructose, sodium chloride, water for injection.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| GlycerolIngredients |
Hyperosmotic dehydration can reduce brain water content and intracranial pressure. It enters the cerebrospinal fluid and brain tissue more slowly and is cleared more slowly. Most of it is metabolized into CO2 and water and excreted. More |
56-81-5 | 61 | |
| beta-D-FructopyranoseIngredients |
Hyperosmotic dehydration can reduce brain water content and intracranial pressure. It enters the cerebrospinal fluid and brain tissue more slowly and is cleared more slowly. Most of it is metabolized into CO2 and water and excreted. More |
7660-25-5 | 14 | |
| Sodium chlorideIngredients |
[Pharmacology and Toxicology] Glycerol fructose injection is a hypertonic preparation. Through high osmotic dehydration, it can reduce the water content of the brain and reduce intracranial pressure. This product has a slow onset of action in reducing intracranial pressure and lasts for a long time. [Pharmacokinetics] This product enters the body tissues through the blood, and its distribution reaches equilibrium in about 2 to 3 hours. It enters the cerebrospinal fluid and brain tissue slowly and is cleared slowly. Most of this product is metabolized to CO2 and water for excretion. More |
7647-14-5 | 43 |
Appearance
This product is a colorless, clear liquid; it tastes slightly sweet and slightly salty.
Indication
It is used for acute and chronic increased intracranial pressure, cerebral edema, etc. caused by cerebrovascular disease, brain trauma, brain tumors, intracranial inflammation and other reasons.
Usage and Dosage
For intravenous drip, adults usually take 250-500 ml at a time, 1-2 times a day, 500 ml each time needs to be dripped for 2-3 hours, 250 ml needs to be dripped for 1-1.5 hours. The dosage can be increased or decreased appropriately according to age and symptoms.
Adverse Reactions
This product generally has no adverse reactions, but hemolysis may occasionally occur.
Precautions
1. It is contraindicated for patients with hereditary fructose intolerance. 2. It should be used with caution for patients with severe circulatory system dysfunction, diabetes insipidus, and diabetes.
Drug Interactions
Not yet clear.
Storage
Keep tightly closed.
Packaging Specification
250ml
Manufacturer
Jiangsu Embrace Sicence & Technology Development Co., Ltd.
-
Founded in:
2017-03-15 -
Address:
No. 29-2, Yingbin Avenue, Huai'an Economic and Technological Development Zone -
Tax NO.:
91320891MA1NK66M3L -
Registered Funds:
60 million yuan -
Email: